Parnax Lab

Parnax Lab Forward P/E

The Forward P/E Ratio of Parnax Lab (506128.BO) as of Nov 14, 2026 is 12.39. In the previous year, Forward P/E Ratio was 14.86 — a change of -16.58% (lower).

Forward P/E

12.39

YoY

-16.58%

Last updated:

Forward P/E Ratio of Parnax Lab is 2025 12.39 . Forward P/E Ratio of Parnax Lab was 2024 14.86 . It decreases by -16.58% lower compared to the previous year.

The Parnax Lab Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
135.46 INR
Jan 1, 2019
43.28 INR
Jan 1, 2020
-48.99 INR
Jan 1, 2021
-392.21 INR
Jan 1, 2022
17.32 INR
Jan 1, 2023
16.56 INR
Jan 1, 2024
14.86 INR
Jan 1, 2025
12.39 INR
The Parnax Lab Forward P/E history
YEARForward P/EYoY
12.39-16.58%
14.86-10.31%
16.56-4.36%
17.32-104.42%
-392.21+700.66%
-48.99-213.19%
43.28-68.05%
135.46+240.59%
39.77-30.13%
56.93+69.76%
33.53-41.42%
57.25—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

Forward P/E Ratio of Parnax Lab is 12.39 in 2025.

Forward P/E Ratio of Parnax Lab changed from 14.86 to 12.39, representing a -16.58% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Parnax Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Parnax Lab

All Key Metrics — Parnax Lab